Sort
27,075 grants matching “cholesterol”
HDL Function in Human Disease
$2,388,576Macrae F Linton · Vanderbilt University Medical Center · P01 · FY2016 · HL
Systemic Autoimmunity
$2,386,053Mariana Kaplan · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR
SPORE in Pancreatic Cancer
$2,379,383Michael A Hollingsworth · University Of Nebraska Medical Center · P50 · FY2017 · CA
Pannexin Channels In Vascular Physiology & Inflammation
$2,378,927Kodi S Ravichandran · University Of Virginia · P01 · FY2016 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,378,927Kodi S Ravichandran · University Of Virginia · P01 · FY2018 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,378,927Kodi S Ravichandran · University Of Virginia · P01 · FY2017 · HL
Pannexin channels in vascular physiology and inflammation
$2,378,927Kodi S Ravichandran · University Of Virginia · P01 · FY2014 · HL
CS6253 development for the treatment of apoE4 driven dementia includingAlzheimer's disease
$2,375,985Jan Johansson · Artery Therapeutics, Inc. · R44 · FY2020 · AG
Center of Biomedical Research Excellence in Cardiovascular Health
$2,374,059David G Edwards · University Of Delaware · P20 · FY2024 · GM
Genetics of Atherosclerosis in Mexican Americans
$2,373,182Southwest Foundation For Biomedical Res · P01 · FY2005 · HL
Cardiovascular Disease and Diabetes Program Project
$2,367,774Karin E. Bornfeldt · University Of Washington · P01 · FY2016 · HL
Probing the functional heterogeneity of high-density lipoprotein using physiological biomimicry
$2,367,000Yongtae Kim · Georgia Institute Of Technology · DP2 · FY2017 · HL
HDL Function in Human Disease
$2,364,164Macrae F Linton · Vanderbilt University · P01 · FY2014 · HL
Carbohydrate: Amount and Type Affecting Risk for CVD and Diabetes
$2,362,602Frank M Sacks · Brigham And Women'S Hospital · R01 · FY2008 · HL
New Genes and Pathways Involved in Atherosclerosis
$2,362,079Alan Richard Tall · Columbia University Health Sciences · P01 · FY2009 · HL
Triglycerides, Diabetes and Cardiovascular Disease
$2,360,354Karin E. Bornfeldt · University Of Washington · P01 · FY2022 · HL
Immune Cell Interactions in Atherosclerosis
$2,358,435Catherine C Hedrick · Augusta University · P01 · FY2025 · HL
Immune Cell Interactions in Atherosclerosis
$2,358,435Catherine C Hedrick · Augusta University · P01 · FY2022 · HL
Immune Cell Interactions in Atherosclerosis
$2,358,435Catherine C Hedrick · Augusta University · P01 · FY2023 · HL
HDL Structure and its Function in Atherosclerosis
$2,352,233Stanley L Hazen · Cleveland Clinic Lerner Com-Cwru · P01 · FY2010 · HL
Oxidative Modification Of Proteins
$2,349,167Rodney L. Levine · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
Center of Biomedical Research Excellence in Cardiovascular Health
$2,347,347David G Edwards · University Of Delaware · P20 · FY2022 · GM
Disease Model Development and Phenotyping Project
$2,345,210Gareth R Howell · Indiana University Indianapolis · U54 · FY2019 · AG
Carbohydrate: Amount and Type Affecting Risk for CVD and Diabetes
$2,343,716Frank M Sacks · Brigham And Women'S Hospital · R01 · FY2009 · HL
Pannexin Channels In Vascular Physiology & Inflammation
$2,343,243Kodi S Ravichandran · University Of Virginia · P01 · FY2015 · HL